Skip to main content
. Author manuscript; available in PMC: 2010 Nov 5.
Published in final edited form as: Hypertension. 2010 Mar 19;55(6):1331–1338. doi: 10.1161/HYPERTENSIONAHA.109.146795

Table 2.

Background Characteristics of Sample

Variable Treatment Group
DASH+WM (n=43) DASH-A (n=38) Control (n=38) Full Cohort (n=124)
Men, n (%) 15 (35) 15 (39) 15 (35) 45 (36)
Whites, n (%) 29 (74) 17 (47) 22 (54) 68 (59)
Age, y 52.9 (10.4) 52.3 (9.5) 51.7 (9.0) 52.3 (9.6)
College degree, n (%) 27 (63) 23 (61) 18 (42) 68 (55)
IMT, mm 0.68 (0.17) 0.70 (0.11) 0.71 (0.13) 0.70 (0.14)
FSRP 6.0 (2.6) 6.2 (3.2) 5.8 (2.5) 6.0 (2.8)
Clinic SBP, mm Hg 138.6 (8.1) 137.5 (8.5) 138.6 (8.7) 138.3 (8.4)
Clinic DBP, mm Hg 85.4 (7.2) 87.2 (6.4) 85.7 (5.9) 86.1 (6.5)
Peak oxygen consumption, mL/kg per min 23.7 (6.5) 23.5 (6.7) 23.6 (6.0) 23.6 (6.3)
Weight, kg 93.9 (14.5) 93.9 (13.2) 92.8 (15.2) 93.5 (14.3)
BMI, kg/m2 32.8 (4.1) 32.8 (3.4) 32.7 (3.9) 32.8 (3.8)

Data are given as mean (SD) unless otherwise indicated. FSRP indicates Framingham Stroke Risk Profile.